Evidence map›Paper›PMID 41065752›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

Integrated Multiomic Analysis Reveals the Therapeutic Potential of Danhong Injection in Mitigating Radiation-Induced Heart Disease by Modulating Ferroptosis.

Bo-Wen Wang, Gang Wang, Zhan Zhang, Wei-Jie Lu, Yan-Ling Li, Yan-Biao Shu, Ping Xie

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Integrated Multiomic Analysis Reveals the Therapeutic Potential of Danhong Injection in Mitigating Radiation-Induced Heart Disease by Modulating Ferroptosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bo-Wen WangSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
Gang WangThe First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
Zhan ZhangDepartment of Cardiovascular Medicine, Gansu Provincial Hospital, Lanzhou, China.
Wei-Jie LuSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
Yan-Ling LiSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
Yan-Biao ShuThe First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China.
Ping XieSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, China.ORCID https://orcid.org/0000-0002-9004-9590

Funding

Gansu Provincial Hospital Internal Fund Project 22GSSYD-14Major Project of Gansu Province Joint Research Fund 24JRRA886MOST | National Natural Science Foundation of China (NSFC) 82460051| Natural Science Foundation of Gansu Province (Gansu Natural Science Foundation) 23JRRA1287
6 · The paper itself

Abstract

Radiation-induced heart disease (RIHD) has garnered increasing clinical attention. While oxidative stress plays a pivotal role in RIHD pathogenesis and progression, the involvement of ferroptosis-a regulated cell death pathway closely linked to oxidative stress-remains poorly characterized. Danhong injection (DHI), a clinically approved traditional Chinese medicine, is widely used for treating cardiovascular disorders because of its anti-inflammatory and antioxidant properties. Therefore, we investigated whether DHI exerts therapeutic effects against RIHD by suppressing ferroptosis. We established both in vivo and in vitro RIHD models. Ferrostatin-1 (Fer-1), a selective ferroptosis inhibitor, was used as a positive control. Mice and cardiomyocytes (H9C2 and AC16 cell lines) were treated with DHI postirradiation. Myocardial tissue/cellular/mitochondrial damage was comprehensively assessed through histopathological and functional analyses. Oxidative/antioxidant imbalance was quantified via biochemical assays, and ferroptosis-related protein expression was evaluated using immunohistochemistry and Western blotting. Finally, transcriptomic and metabolomic sequencing, coupled with bioinformatics approaches, was performed using murine myocardial tissues to elucidate molecular alterations. X-irradiation induced structural and functional damage in myocardial tissues and cells, accompanied by oxidative stress and ferroptosis activation. DHI treatment significantly mitigated those effects, restoring myocardial integrity and viability. Differentially expressed genes and metabolites were predominantly enriched in immune response pathways and metabolic reprogramming processes. Promising RNA-metabolite interactions that may serve as therapeutic targets for future investigations were revealed. DHI ameliorates RIHD by inhibiting ferroptosis. Integrated multiomics not only validated the therapeutic potential of DHI but also provided novel insights into the molecular mechanisms underlying radiation-induced cardiac injury.

Indexed as

Drugs, Chinese HerbalFerroptosisHeart DiseasesRadiation InjuriesAnimalsCell LineMaleMiceMice, Inbred C57BLMyocytes, CardiacOxidative StressRatsdanhongDrugs, Chinese Herbal

Identifiers

PMID41065752
PMCPMC12510299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.